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Plasmodium falciparum proteins involved in erythrocyte invasion are main targets of acquired 
immunity and important vaccine candidates. We hypothesized that anti-parasite immunity acquired 
upon exposure would limit invasion-related gene (IRG) expression and affect the clinical impact of the 
infection. 11 IRG transcript levels were measured in P. falciparum isolates by RT-PCR, and IgG/IgM 
against invasion ligands by Luminex®, in 50 Mozambican adults, 25 children with severe malaria (SM) 
and 25 with uncomplicated malaria (UM). IRG expression differences among groups and associations 
between IRG expression and clinical/immunologic parameters were assessed. IRG expression diversity 
was higher in parasites infecting children than adults (p = 0.022). eba140 and ptramp expression 
decreased with age (p = 0.003 and 0.007, respectively) whereas p41 expression increased (p = 0.022). 
pfrh5 reduction in expression was abrupt early in life. Parasite density decreased with increasing pfrh5 
expression (p < 0.001) and, only in children, parasite density increased with p41 expression (p = 0.007), 
and decreased with eba175 (p = 0.013). Antibody responses and IRG expression were not associated. In 
conclusion, IRG expression is associated with age and parasite density, but not with specific antibody 
responses in the acute phase of infection. Our results confirm the importance of multi-antigen vaccines 
development to avoid parasite immune escape when tested in malaria-exposed individuals.
By invading host cells, apicomplexan parasites can develop in a rich nutrient environment while being protected 
from host defenses. In Plasmodium falciparum, invasion of red blood cells (RBC) by merozoites is mainly driven 
by the cooperative function of ligands from the P. falciparum reticulocyte-binding homolog (PfRh) and the 
erythrocyte-binding antigen (EBA) families1–3. In addition, many ligands that do not belong to these families 
have been identified as having key roles during RBC invasion4–6. The expression of invasion-related genes (IRG) 
during schizont stages7 is tightly regulated as part of the parasite life cycle8, 9. Depending on the nature of the 
RBC receptor used, the invasion phenotype can be classified as sialic acid (SA)-dependent or SA-independent10. 
Some invasion ligands have been linked to each of these two phenotypes in culture-adapted parasite lines namely 
PfRh1, EBA175, and EBA140 to SA-dependent pathway11 and PfRh2a, PfRh2b and PfRh4 to SA-independent 
pathway12–17. Inverse correlations in expression between genes involved in opposite pathways (pfrh1 vs. pfrh2b) 
have been observed in natural isolates from Kenya18 and Tanzania19. However, it was observed that the same 
invasion phenotype does not always involve the same gene expression pattern8.
The essential process of RBC invasion is extremely rapid20, probably for minimizing the exposure of mero-
zoites to host-derived antibodies targeting invasion ligands. This immune recognition can lead to inhibition of the 
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parasite replication or killing and therefore constitute a selection pressure on the parasite population5. Antibodies 
to a range of merozoite invasion ligands are acquired through exposure to malaria and have been associated 
with protection from clinical illness21. In return, the parasite has developed immune evasion strategies through 
the high polymorphism22, functional redundancy or gene variant expression of critical invasion ligands8, 13, 23. 
Indeed, the parasites that survive during an infection are thought to express variants corresponding to gaps in the 
repertoire of host antibodies24, and variation in invasion ligand use by the parasite during RBC invasion has been 
shown to mediate evasion of inhibitory antibodies25, 26. Consequently, this immune pressure may modulate IRG 
expression, as it is hypothesized for eba17527, 28, and changes in EBA175 expression and/or use by the parasite alter 
the susceptibility to acquired inhibitory antibodies25. Interestingly, few studies have reported that particular tran-
scripts of IRG correlate with parasitemia, age or endemicity levels28, 29. Moreover, differences have been reported 
in multiplication rates and invasiveness in natural isolates from Thai patients with severe (SM) and uncomplicated 
(UM) malaria30, 31. However, no differences have been found between SM and UM patients in other parasite pop-
ulations regarding multiplication rates, RBC selectivity, invasion phenotypes32, 33 or IRG expression levels18, 28.
The immune escape of parasites caused by exposure to vaccine-induced anti-malarial immunity can be min-
imized if the IRGs whose expression is modulated by immune pressure are identified34. Therefore, this kind of 
studies can help to adapt vaccination strategies based on the predicted change in malaria transmission intensity 
(and therefore in accumulated exposure) caused by malaria control and elimination campaigns. Here we aimed 
to study the gene expression levels of IRGs in P. falciparum isolates collected from Mozambican individuals with 
different levels of previous exposure to malaria parasites, defined by their age or their antibody responses against 
P. falciparum antigens. We hypothesized that anti-parasite immunity acquired after years of exposure would limit 
the expression of IRG by the infecting parasites and determine the clinical impact of the infection. To address 
this, we compared IRGs expression in parasites infecting adults and children from the same area and studied the 
association with their immune status and clinical outcomes.
Materials and Methods
Study area and population. The study was conducted in the Manhiça District, southern Mozambique35, 
where a demographic surveillance system (DSS) set up in 1998 by the Centro de Investigação em Saúde de 
Manhiça (CISM), currently provides accurate demographic information on its circa 178,000 inhabitants. The 
region has a warm and rainy season from November to April, and a cooler and drier season the rest of the year. 
Malaria transmission is perennial with some seasonality. Plasmodium falciparum is the predominant species, and 
Anopheles funestus the main vector. Entomological inoculation rate in 2002 was 38 infective bites/person/year35.
Patients attending the Manhiça District Hospital with a clinical diagnosis of P. falciparum malaria 
were recruited into the study after obtaining written informed consent. Samples were collected between 
April-November 2006 (children; n = 25 SM patients and n = 25 UM patients) and August 2006 to May 2008 
(adults, n = 50, UM). Clinical malaria was defined as the presence of fever (axillary temperature ≥ 37.5 °C) with 
an asexual parasitemia of P. falciparum ≥ 500/μL on thin blood film examination. SM was defined when children 
had, at least, one of the following symptoms: cerebral malaria (Blantyre Coma Score ≤ 2), severe anemia (packed 
cell volume < 15% or hemoglobin < 5 g/dL), acute respiratory distress (lactate > 5 mM and/or chest indrawing 
or deep breathing), prostration, hypoglycemia (blood glucose < 2,2 mM) and multiple seizures ( ≥ 2 convulsions 
in the preceding 24 h)36. Individuals with UM were those with clinical malaria not showing any of the men-
tioned signs of severity. Parasite density was determined by optic microscopy. Peripheral blood was collected 
by venipuncture before treatment. Following centrifugation, the RBC pellet was cryopreserved in liquid nitro-
gen36. The studies were approved by the Mozambican National Bioethics Committee and the Hospital Clínic of 
Barcelona Ethics Review Committee and all experiments were carried out in accordance with relevant guidelines 
and regulations.
Parasite culture and quantification of transcript levels. Cryopreserved P. falciparum isolates were 
thawed and matured as previously described36. Cultures were monitored by Giemsa-stained thin smears for 
18–56 hours until most schizont stages were observed, as determined by the agreement of two trained researchers. 
Infected RBCs were collected, washed with PBS, mixed with 20 V of TRIzol® and RNA was obtained following 
manual extraction with phenol/chloroform phase separation. Total RNA was treated with Turbo DNA-free™ kit 
(Ambion) at 37 °C for 45 minutes and reverse transcribed with oligo(dT) using Maxima H reagents (Thermo 
scientific).
Quantitative PCR (qPCR) was performed on an ABI PRISM-7500 real-time system (Applied Biosystems) 
using 2μL of cDNA in a final volume of 20μL, including 10μL of Power SYBR green master mix (Applied 
Biosystems) and primers for specific genes at the convenient concentration (see Supplementary Table 1). 
Gene-specific primers were designed to match conserved regions only in P. falciparum based on the coding 
sequence (GeneBank) and rechecked with sequences available in www.plasmodb.org on October 2015. Human 
DNA was not amplified with any primer. To obtain transcript concentration from each sample, the mean Ct 
(duplicates) of the sample was interpolated to a 7-point 10-log standard curve with 3D7 genomic DNA of known 
concentrations, for each of the studied genes. Samples with a Ct > 30 for the housekeeping gene (Seryl tRNA 
synthetase) were discarded, and samples with a Ct higher than the higher Ct from each gene’s standard curve, 
were considered as not expressed. Each IRG transcript level was normalized as a proportion of the sum of all 
transcripts concentrations in each isolate and reported as a percentage of expression (relative transcript levels). 
Expression was considered only if relative transcript level was higher than 0. Multiplicity of infection in children 
was measured as described elsewhere37.
Antibody measurement. Apical asparagine-rich protein (AARP), Plasmodium Thrombospondin-related 
apical merozoite protein (PTRAMP), EBA175PfF2, PfRh1, PfRh2a/b, PfRh430, PfRh4C-terminal, PfRh5, P41 and 
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Cysteine-rich protective antigen (CyRPA) were produced at the International Centre for Genetic Engineering 
and Biotechnology (ICGEB)38–42. PfRh22030–2528 and regions III–V of EBA175 (EBA175III–V) and EBA140 
(EBA140III–V) were produced at the Burnet Institute26, 43, 44. Recombinant proteins were expressed in Escherichia 
coli. IgG and IgM responses targeting P. falciparum antigens were measured by quantitative suspension array 
technology (qSAT) in multiplex using xMAP™ beads (Luminex Corporation) coupled to each antigen. Positive, 
negative and background controls were added to each plate. Multiplexed beads were incubated with plasma 
samples, and antibody levels were measured as described elsewhere45, 46. Median Fluorescence Intensity (MFI) 
was obtained from the InVitrogen Luminex® platform (xPONENT® Software, at least 100 counts/analyte) and 
normalized for inter-plate variability by multiplying individual values by the median value of a positive control 
assayed in all plates and dividing by each plate’s value. Negative values were substituted by the minimum positive 
value divided by two in order to log-transform these variables.
Definitions and statistical analysis. Age was categorized as < 2.5 years; 2.5 years to ≤ 5; 14 to < 22 years 
and 22 to ≤ 61 years according to quartile distribution. Seropositive threshold was defined as the mean plus 
3 standard deviations of the value of the negative population given by finite mixture models estimated with 
log-transformed antibody levels. Breadth of antibody responses was defined as the sum, for each individual, of 
the number of specific antibodies above the seropositive threshold. The ratio for genes from the SA-dependent/
SA-independent pathways was obtained from eba175, eba140 and pfrh1 for SA-dependent and from pfrh2a, 
pfrh2b and pfrh4 for SA-independent pathways. The diversity of gene expression in each P. falciparum isolate was 
defined as the number of genes with transcripts detected by qPCR.
To compare mean levels or prevalence between groups, we used Student’s t-test (or Wilcoxon rank-sum test if 
the variable was not normally distributed) and chi-square test, respectively. Spearman’s correlations were calcu-
lated to assess strength of the relationship between IRG levels and parasite density. Comparisons between more 
than two groups were done with Kruskal-Wallis test for non-normally distributed data. To assess the associa-
tion between variables, we performed crude and adjusted linear regression models, including interaction terms 
with age. Wald’s test was used to assess the overall effect of age on relative transcript levels. Reported p-values 
were not adjusted for multiple comparisons21, 47 and therefore, the interpretation of results is based on the stand-
ard significance level (p < 0.05) and on the magnitude of the effect. Statistical analyses were performed using 
Stata (StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP) and graphs with 
Prism7 (GraphPad).
Results
The 100 clinical Plasmodium falciparum isolates thawed for ex vivo culture developed and reached late tro-
phozoite/schizont stages. Three of them (3%) were discarded due to a Ct value > 30 for the housekeeping gene 
(Seryl tRNA synthetase). All plasma samples from adults and children were tested for specific IgG and IgM levels 
against the recombinant proteins produced from the studied genes (except for 1 adult and IgM determination in 
8 children with UM and 4 children with SM due to unavailability of enough plasma volume). Out of the 96 sam-
ples analyzed for transcript and IgG antibody levels, 46 were adults (48%) and 50 children (52%). No statistically 
significant differences in terms of parasitemia, gender or parasites’ maturation time between groups were found 
(Table 1).
Expression of invasion-related genes and specific antibody levels. The most abundant transcripts 
in the studied isolates were from p41, with median relative transcript levels of 15.2% (interquartile range [IQR] 
6.4%, 29.5%), followed by eba140 (12.6% [5.6%, 22.1%]) and ptramp (7.6% [5.7%, 10.7%]), followed by cyrpa 
(6.1% [4.4%, 10.7%]), eba175 (5.9% [0.2%, 14.2%]) and aarp (4.5% [9%, 12%]). Genes from the pfrh family were 
the least expressed (see Supplementary Table 2). No consistent correlation was found for relative transcript levels 
of genes involved in the SA-dependent pathway (eba175, eba140, pfrh1) or the SA-independent pathway (pfrh2a, 
pfrh2b, pfrh4), nor among them (see Supplementary Table 3). No differences were found in the ratio for relative 
transcript levels reflecting SA-dependent or SA-independent pathways among adults, children with SM and chil-
dren with UM (Kruskal-Wallis test, p-value = 0.735). Relative transcript levels did not differ in infections with 
different levels of multiclonality (Kruskal-Wallis test, all p-values > 0.05).
Adults
Children P-value
All UM SM UM-SM Adults vs Children
N 46 50 25 25
Age (years), median (IQR) 24 (18, 34) 2.6 (1.3, 3.5) 2.6 (1.1, 3.3) 2.8 (1.6, 3.6) 0.327a  < 0.0001a
Sex (male % (n)) 47.8% (22) 60% (30) 68% (17) 52% (13) 0.248b 0.232b
Parasitemia (OM, parasites/
uL), median (IQR)
38654.5  
(25924, 82880)
47659.6  
(22927.8, 81632.7)
42989.9  
(19109.2, 73714.3)
50402.4  
(23327.55, 114372.5) 0.327
a 0.760a
Maturation time (hours at 
37 °C), median (IQR) 31.3 (28, 39) 32 (30, 39) 35.5 (31, 39) 32 (30, 38) 0.219
a 0.863a
Table 1. Demographic, clinical and parasitological factors of the infected individuals included in this study. 
aWilcoxon rank-sum test; bChi-square test. Abbreviations: UM, Uncomplicated malaria; SM, Severe malaria; 
IQR, Interquartilic range; OM, Optic Microscopy.
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Relative transcript levels of invasion-related genes, by age and specific antibody levels. The 
median of different transcripts detected within the parasite isolates studied was 10 (9, 12). This median was higher 
in children (11 [11, 12]) compared to adults (10 [9, 12]) (p = 0.022, Fig. 1a). Diversity in IRG expression was 
independent of parasite density (Spearman’s rho = 0.07, p = 0.497). Breadth of IgG antibody responses was higher 
in adults (p < 0.001) and, mirroring the higher diversity in IRG expression in children than in adults, children 
also showed higher breadth in IgM antibody responses than adults (p = 0.0027, Fig. 1b). No association between 
parasite density and IgG or IgM breadth was observed (p > 0.05).
Levels of IgG antibodies against the antigens studied were, in general, higher in adults than children: EBA175 
PfF2 (p = 0.036), EBA175III–V (p < 0.001), P41 (p < 0.001), PfRh1 (p < 0.001), PfRh240 (p < 0.001), PfRh22030 
(p < 0.001), PfRh430 (p < 0.001), PfRh4C-terminal (p < 0.001), PfRh5 (p < 0.001) and PTRAMP (p = 0.039). IgM 
levels were higher in children for antibodies against PfRh430 (p = 0.047), PfRh240 (p = 0.039) and EBA140 III–V 
(p = 0.021). Specific IgG and IgM antibody levels are showed in Fig. 1c,d, respectively. No differences in antibody 
levels were found between children with SM or UM, except for IgM against P41 (p = 0.008) and IgM against 
CyRPA (p = 0.037), both being higher in UM compared to SM patients.
Figure 1. Diversity of invasion-related gene expression, breadth of antibody antibody responses and specific 
antibody levels against invasion-related antigens in Mozambican adults and children. (a) Diversity of invasion-
related genes expression in each age group. Children had a higher diversity compared to adults (11 and 10, 
respectively, Wilcoxon rank-sum test, p = 0.022). Median values with the 95% confidence intervals are shown. 
(b) Breadth of antibody responses of specific IgG and IgM responses in age groups. Adults have higher breadth 
of IgG antibody responses against malaria antigens than children (Wilcoxon rank-sum test, p < 0.001) whereas 
children have higher breadth of IgM antibody responses (Wilcoxon rank-sum test, p = 0.003). Median values 
with the 95% confidence intervals are shown. (c,d) Specific IgG (c) and IgM (d) levels in adults and children. 
*p < 0.05; **p < 0.01; ***p < 0.001. Grey dots represent values for children and empty dots values for adults. 
Median values are represented by horizontal black lines.
www.nature.com/scientificreports/
5Scientific RepoRts | 7: 4717  | DOI:10.1038/s41598-017-05025-5
Relative transcript levels of eba140 and ptramp were lower in older than in younger individuals (p = 0.003 and 
p = 0.007, respectively), while p41 relative transcript levels increased with age (p = 0.022) (Fig. 2a). The expression 
of eba140, ptramp and p41 by infecting parasites showed a gradual change as the age of the host increased. In con-
trast, pfrh5 relative transcript levels were higher in children than in adults (Wilcoxon rank-sum test, p = 0.013), 
and decreased abruptly during firsts years of life and reached the lowest levels in parasite infecting young adults 
(Wilcoxon rank-sum test, p = 0.023, Fig. 2b). Among children, p41 was more expressed in parasite isolates from 
children with SM (p = 0.048) than with UM (Fig. 3). This difference was slightly higher when only considering 
those samples with p41 transcripts detected (p = 0.043). Interestingly, higher levels of relative transcript levels 
for eba175 in parasites causing UM compared to SM was only found when considering parasites with eba175 
transcripts detected (p = 0.03).
No consistent relationships between relative transcript levels and specific antibodies (IgG and IgM) against 
the recombinant merozoite antigens were found (Supplementary Table 4). Despite IgG breadth being higher 
in adults than in children and IgM breadth higher in children than in adults, no general association was found 
between breadth of IgG or IgM antibody responses and IRG relative transcript levels (Supplementary Figure 1a,b, 
respectively). Interaction with age was only significant for ptramp relative transcript levels and IgG breadth. The 
association between IgG breadth and ptramp relative transcript levels was only significant in children (Coefficient 
−0.93 [95% confidence interval −0.29, −1.70]; p = 0.007). Therefore, data presented in Supplementary Figure 1 
was not stratified.
Transcript levels of invasion-related genes are associated with parasite density. Parasite density 
had a proportional increase of 1.3 (95% CI 1.1, 1.5; p = 0.007) with a 10% increase in p41 relative transcript levels. 
In contrast, parasite density decreased with increasing levels of eba175 (Coef. 0.7 [95% CI 0.5, 0.9]; p = 0.013) 
and pfrh5 (Coef. 0.2 [95% CI 0.1, 0.5]; p < 0.001), (Fig. 4a). The relationship of eba175 and p41 relative transcript 
levels with parasite density was affected by the fact of being an adult (age groups from 14 to < 22 and 22 to ≤ 61 
years old) or children (age groups from 0 to < 2.5 and 2.5 to < 5 years old) (p-values of interaction = 0.021 and 
0.005, respectively). After stratifying the analysis, it was observed that in children, but not in adults, parasite 
density was positively associated with p41 relative transcript levels (Coef. 1.8 [95% CI 1.3, 2.5]; p = 0.001) and 
negatively associated with eba175 (Coef. 0.5 [95% CI 0.3, 0.8]; p = 0.005) (Fig. 4a). In contrast, the reduction of 
parasite density with increasing relative transcript levels of pfrh5 was similar in children (Coef. 0.2 [95% CI 0.03, 
Figure 2. Association of age with invasion-related gene relative transcript levels. (a) Mean difference between 
age groups and 95% confidence interval from linear regression models, adjusted by density of infection, where 
the reference group was the youngest children (less than 2.5 years of age). *P-values from Wald’s test for 
significant associations of any age group with IRG relative transcript levels. (b) Relative transcript levels of IRG 
with significant associations with age by age groups. Significant differences between age groups by Wilcoxon 
rank-sum test are specified.
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0.7]; p = 0.02) and adults (Coef. 0.3 [95% CI 0.1, 0.8]; p = 0.01), (Fig. 4a). Parasite density for each tertile of pfrh5 
relative transcript levels is shown in Fig. 4b.
Discussion
This is, to our knowledge, the first study to analyze the expression of a wide array of P. falciparum genes involved 
in invasion among parasite isolates collected from Mozambican individuals covering a broad range of ages, from 
early infancy to late adulthood. Such an approach allowed us to identify invasion-related genes (IRG) whose 
relative transcript levels vary depending on the age of the infected host. The relative transcript levels of eba140, 
ptramp and pfrh5 were the highest in parasites infecting young individuals, while p41 relative transcript levels 
were the highest in older individuals. This points out how different histories of previous exposure can modulate 
the expression of genes involved in RBC invasion, probably due to the development of antimalarial immunity 
upon exposure to the parasite.
The diversity of IRG expression was higher in children than in adults. Such diversity was not associated with 
parasite density and therefore a sensitivity issue due to cDNA available during the qPCR procedure, which could 
bias our results, can be discarded. Thus, it is shown that older individuals have a higher ability to limit the diver-
sity of IRG transcripts during an infection compared to children24, and presumably select the parasites express-
ing a reduced IRG repertoire. Among the specific IRG analyzed, eba140, ptramp and pfrh5 were found to be 
more expressed in children than in adults, while p41 was less expressed in children than in adults. The decrease 
in diversity of IRG expression with age is also probably due to the decrease in relative transcript levels of the 
IRG described here (except for p41). No associations were found between specific antibody levels and IRG rel-
ative transcript levels. This may be because antibodies were measured at the acute phase of infection, when an 
overall boosting of immune responses is generally observed48. Alternatively, levels of antibodies may not accu-
rately reflect their functional inhibitory activity26, 49, 50 and therefore not fully representing the selective pressure 
of immunity on ligand expression. In addition, the role of other immune effectors or a global immune action 
(including humoral and cellular responses) cannot be discarded, as well as the possibility of a general reset of the 
epigenetic machinery during transmission stages51, which in early phases of infection would restart IRG expres-
sion. This expression might then be shaped in the first rounds of invasion depending on the host’s antimalarial 
immunity.
The reduction of the relative transcript levels of eba140, ptramp and pfrh5 with age can be due to the pressure 
exerted by the acquired anti-malarial immunity, which increases with age in our study population. It is possible 
that these invasion ligands may be naturally expressed at moderate to high levels in the absence of a selective pres-
sure24. During an infection, this would turn into a very low-restricted expression of these IRG upon exposure to 
immune effectors. This change in expression levels would be even more rapid when the ligand targeted is highly 
conserved and/or essential for the parasite survival42, 52, such as pfrh5, as we have observed. This can explain the 
consistent association described in this study between high relative transcript levels of pfrh5 and lower parasite 
densities, contrary to what was previously described28, 29: the more pfrh5 expressed, the more exposure to the 
immune system and therefore higher selective pressure in favor of those parasites expressing less pfrh553. This 
observation is consistent with the epidemiological pattern where infection densities decrease with increasing age in 
malaria endemic areas26. However, it cannot be discarded that the differences observed with age are due to factors 
other than anti-malarial immunity developed upon exposure, such as maturity or the immune system itself 54, 55.
In this study, p41 relative expression was positively associated with age and, only in children, with higher 
parasite densities. In this population, expression of p41 was slightly higher in parasites infecting children 
with SM, than UM (although very borderline significance). We also report higher IgM levels against P41 
in children with UM compared to children with SM, maybe reflecting a protective role of IgMs against 
severe malaria. All together suggest that p41 might be important in the success of the invasion process and 
Figure 3. Relative transcript level of invasion-related genes in children with severe and uncomplicated malaria. 
Transcript levels are shown for individual isolates and median values with the 95% confidence interval for each 
group; significant differences are specified (Wilcoxon rank-sum test, p < 0.05). IRG relative transcript levels of 
each P. falciparum isolate is represented with black triangles for parasites from severe malaria patients and with 
grey circles for parasites from uncomplicated malaria patients.
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affected by anti-parasite host immunity. However, the mechanisms remain still unknown, since p41 is the 
only gene studied here that has not been directly linked to invasion56. More studies will be useful to both 
determine the role of p41 in the parasite’s biology as well as the effect of specific antibodies in protection 
against malaria severity.
In the case of eba175, its expression levels were slightly higher in children with UM compared to SM, although 
it did not reach statistical significance. This is in accordance with previous results28 showing that invasion by par-
asites causing UM had the higher dependence on trypsin (and a trend to neuraminidase-sensitive phenotype). 
Interestingly, isolates from The Gambia showed that SA-dependent invasion is more common among infections 
in children57. Also, although it is not always linked to SA-dependent pathway58, it has been hypothesized that 
eba175 can be more expressed in non-immune individuals28. In addition, the acquisition of inhibitory antibod-
ies against antigens from the SA-dependent pathway may be acquired early in life25. Here, we show that IgG 
levels against antigens from the SA-independent pathway (PfRh2 and PfRh4, Fig. 1c) are much higher in adults 
than in children; early antibody responses (IgM) against PfRh4 are lower in adults; and that expression of the 
SA-dependent pathway antigen eba140 is lower in adults. Taken together, these evidences suggest the possibility 
that what is being selected in parasites infecting immune individuals is the invasion phenotype rather than inva-
sion ligands themselves, although further studies are needed.
This study has some limitations that need to be considered. First, we cannot discard that differences in the 
relative transcript levels between parasites collected from children and adults are due to different duration of the 
infections, which could affect IRG expression levels. Second, the maturation process of multi-clonal infections 
could lead to the selection of those clones with higher maturation rates. Given that there is no reference gene 
to normalize for maturation stage, transcript levels were expressed as relative to the sum of all genes studied to 
control for temporal transcript patterns during cell cycle development, as has been done in previous studies27, 28. 
Third, there may be a lack of concordance between transcript and protein levels for the merozoite proteins 
expressed by field isolates18, 19. Also, it has not been possible to study the invasion phenotype, which would have 
helped to clarify its relationship with previous malaria exposure. Finally, the possibility of type I errors derived 
from analyses reporting non-adjusted p-values should be taken into account47, and, although the overall results 
of our study suggest that expression of genes is modulated by factors modified by age, other studies would be 
required to confirm this statement.
In conclusion, this study shows that the expression of invasion ligands used by P. falciparum to invade RBCs 
can be modulated by the age of the infected host, possibly as a surrogate of immunity. These results suggest that 
the efficacy of malaria vaccines aiming to block the invasion process may differ between individuals with dif-
ferent levels of malaria exposure. Also, the observation that children (or non-immune individuals) are infected 
by parasites expressing a more diverse IRG repertoire, supports the potential need of combining several RBC 
binding ligands in a multi-antigenic vaccine to avoid that the parasite escapes the immune responses induced by 
single-target vaccines. Finally, results reported here suggest that the loss of immunity associated with reductions 
in malaria transmission after elimination or control campaigns, could lead to a change in the repertoire of IRG 
expressed by the remaining parasite population, and therefore to changes in the efficacy of invasion-blocking 
vaccines.
Figure 4. Association of invasion-related genes (IRG) relative transcript levels and parasite density. (a) Effects 
of 10% increase in relative transcript levels on parasite density by optic microscopy (linear regression models 
adjusted by age and clinical presentation) are shown with the 95% confidence interval for each specific IRG. 
Black symbols represent significant associations between IRG relative transcript levels and parasite density. 
From left to right: all population, only children and only adults. (b) Parasite density by optic microscopy 
according to tertile categorization of pfrh5 relative transcript levels in the parasite population.
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